Search the collection

33 results for Durgam,+Suresh

Sort by:

Sort by

Limit results to:

20 per page

33 results for Durgam,+Suresh

Export to excel

Export record to excel

File type to download

Beta version

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
ArticlesPeer ReviewedFull Text
Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial
Author / Creator:Németh, György, Dr ; Laszlovszky, István, PharmD ; Czobor, Pál, PhD ; Szalai, Erzsébet, MD ; Szatmári, Balázs, MD ; Harsányi, Judit, MD ; Barabássy, Ágota, MD ; Debelle, Marc, MD ; Durgam, Suresh, MD ; Bitter, István, Prof ; Marder, Stephen, Prof ; Fleischhacker, W Wolfgang, Prof
Publisher:England: Elsevier Ltd
Journal title:The Lancet (British edition), 2017-03, Vol.389 (10074), p.1103-1113
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
ArticlesPeer ReviewedFull Text
The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis
Author / Creator:Nasrallah, Henry A. ; Earley, Willie ; Cutler, Andrew J. ; Wang, Yao ; Lu, Kaifeng ; Laszlovszky, István ; Németh, György ; Durgam, Suresh
Publisher:England: BioMed Central Ltd
Journal title:BMC psychiatry, 2017-08, Vol.17 (1), p.305-305, Article 305
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 3
ArticlesPeer ReviewedFull Text
Relationship Between Plasma Concentrations and Clinical Effects of Cariprazine in Patients With Schizophrenia or Bipolar Mania
Author / Creator:Periclou, Antonia ; Willavize, Susan ; Jaworowicz, David ; Passarell, Julie ; Carrothers, Timothy ; Ghahramani, Parviz ; Durgam, Suresh ; Earley, Willie ; Kapás, Margit ; Khariton, Tatiana
Publisher:United States: John Wiley & Sons, Inc
Journal title:Clinical and translational science, 2020-03, Vol.13 (2), p.362-371
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 4
ArticlesPeer ReviewedFull Text
Lumateperone in Pooled Late-Phase Schizophrenia Trials: Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed
Author / Creator:Citrome, Leslie ; Durgam, Suresh ; Edwards, John B ; Davis, Robert E
Publisher:New York, USA: Cambridge University Press
Journal title:CNS spectrums, 2023-04, Vol.28 (2), p.243-243
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 5
ArticlesPeer ReviewedFull Text
LUMATEPERONE IN THE TREATMENT OF PATIENTS WITH MAJOR DEPRESSIVE DISORDER AND BIPOLAR DISORDER WITH ANXIOUS DISTRESS AND MIXED FEATURES
Author / Creator:Bhagwagar, Zubin ; Kozauer, Susan G ; Earley, Willie R ; Huo, Jason ; Sachs, Gary S ; Durgam, Suresh
Publisher:US: Oxford University Press
Journal title:The international journal of neuropsychopharmacology, 2025-02, Vol.28 (Suppl 1), p.i316-i316
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 6
ArticlesPeer ReviewedFull Text
LUMATEPERONE TREATMENT FOR MAJOR DEPRESSIVE EPISODES WITH MIXED FEATURES IN MAJOR DEPRESSIVE DISORDER AND BIPOLAR I OR BIPOLAR II DISORDER
Author / Creator:Bhagwagar, Zubin ; Kozauer, Susan G ; Earley, Willie R ; Chen, Changzheng ; Huo, Jason ; Stahl, Stephen ; McIntyre, Roger S ; Durgam, Suresh
Publisher:US: Oxford University Press
Journal title:The international journal of neuropsychopharmacology, 2025-02, Vol.28 (Suppl 1), p.i19-i19
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 7
ArticlesPeer ReviewedFull Text
Safety and tolerability of cariprazine in the long-term treatment of schizophrenia: results from a 48-week, single-arm, open-label extension study
Author / Creator:Durgam, Suresh ; Greenberg, William M. ; Li, Dayong ; Lu, Kaifeng ; Laszlovszky, Istvan ; Nemeth, Gyorgy ; Migliore, Raffaele ; Volk, Stephen
Publisher:Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title:Psychopharmacology, 2017-01, Vol.234 (2), p.199-209
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 8
ArticlesPeer ReviewedFull Text
Lumateperone 42 mg in an Open-Label Switch Study in Patients with Stable Schizophrenia: Results by Previous Antipsychotic
Author / Creator:Cutler, Andrew J ; Edwards, John B ; Durgam, Suresh ; Mo, Yifan ; Acosta, Jazmin ; Davis, Robert E
Publisher:New York, USA: Cambridge University Press
Journal title:CNS spectrums, 2023-04, Vol.28 (2), p.235-236
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 9
ArticlesPeer ReviewedFull Text
Metabolic Syndrome in Bipolar Depression with Lumateperone (ITI-007): A Post Hoc Analysis of 2 Randomized, Placebo-Controlled Trials
Author / Creator:Correll, Christoph U ; Kozauer, Susan G ; Lands, Micah ; Huo, Jason ; Durgam, Suresh
Publisher:New York, USA: Cambridge University Press
Journal title:CNS spectrums, 2023-04, Vol.28 (2), p.247-248
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 10
ArticlesPeer ReviewedFull Text
Effect of Lumateperone (ITI-007) on Quality of Life and Functional Disability in the Treatment of Bipolar Depression
Author / Creator:Edwards, John B ; Durgam, Suresh ; Kozauer, Susan G ; Jain, Rakesh ; McIntyre, Roger S
Publisher:New York, USA: Cambridge University Press
Journal title:CNS spectrums, 2023-04, Vol.28 (2), p.238-238
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 11
ArticlesPeer ReviewedFull Text
Long-Term Lumateperone Treatment in Bipolar Disorder: Six-Month Open-Label Extension Study
Author / Creator:Tohen, Mauricio ; Durgam, Suresh ; Kozauer, Susan ; D’Souza, Ian ; Chen, Richard ; Mates, Sharon
Publisher:New York, USA: Cambridge University Press
Journal title:CNS spectrums, 2023-04, Vol.28 (2), p.233-233
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 12
ArticlesPeer ReviewedFull Text
Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [11C]-(+)-PHNO
Author / Creator:Girgis, Ragy R. ; Slifstein, Mark ; D’Souza, Deepak ; Lee, Yih ; Periclou, Antonia ; Ghahramani, Parviz ; Laszlovszky, István ; Durgam, Suresh ; Adham, Nika ; Nabulsi, Nabeel ; Huang, Yiyun ; Carson, Richard E. ; Kiss, Béla ; Kapás, Margit ; Abi-Dargham, Anissa ; Rakhit, Ashok
Publisher:Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title:Psychopharmacology, 2016-10, Vol.233 (19-20), p.3503-3512
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 13
ArticlesPeer ReviewedFull Text
S221. THE EFFICACY OF LUMATEPERONE 42 MG IN THE TREATMENT OF SCHIZOPHRENIA SYMPTOMS ASSOCIATED WITH SOCIAL FUNCTIONING: POST HOC ANALYSIS OF AN ACUTE PLACEBO- AND ACTIVE-CONTROLLED TRIAL
Author / Creator:Vanover, Kimberly ; Davis, Robert ; Durgam, Suresh ; Huo, Jason ; Mates, Sharon ; Satlin, Andrew ; Harvey, Philip D
Publisher:US: Oxford University Press
Journal title:Schizophrenia bulletin, 2020-05, Vol.46 (Supplement_1), p.S123-S123
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 14
ArticlesPeer ReviewedFull Text
M205. LONG-TERM SAFETY OF LUMATEPERONE (ITI-007): METABOLIC EFFECTS IN A 1-YEAR STUDY
Author / Creator:Satlin, Andrew ; Durgam, Suresh ; Vanover, Kimberly E ; Davis, Robert E ; Huo, Jason ; Mates, Sharon ; Correll, Christoph
Publisher:US: Oxford University Press
Journal title:Schizophrenia bulletin, 2020-05, Vol.46 (Supplement_1), p.S214-S214
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 15
ArticlesPeer ReviewedFull Text
T205. LUMATEPERONE IN THE TREATMENT OF SCHIZOPHRENIA: EVALUATION OF EXTRAPYRAMIDAL AND MOTOR SYMPTOMS IN 4 LATE-PHASE CLINICAL TRIALS
Author / Creator:Durgam, Suresh ; Satlin, Andrew ; Davis, Robert E ; Vanover, Kimberly E ; Mates, Sharon ; Kane, John M
Publisher:US: Oxford University Press
Journal title:Schizophrenia bulletin, 2020-05, Vol.46 (Supplement_1), p.S310-S310
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 16
ArticlesPeer ReviewedFull Text
Evaluation of the long-term safety and tolerability of cariprazine in patients with schizophrenia: results from a 1-year open-label study
Author / Creator:Cutler, Andrew J. ; Durgam, Suresh ; Wang, Yao ; Migliore, Raffaele ; Lu, Kaifeng ; Laszlovszky, István ; Németh, György
Publisher:New York, USA: Cambridge University Press
Journal title:CNS spectrums, 2018-02, Vol.23 (1), p.39-50
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 17
ArticlesPeer ReviewedFull Text
A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Vilazodone in Adolescents with Major Depressive Disorder
Author / Creator:Durgam, Suresh ; Chen, Changzheng ; Migliore, Raffaele ; Prakash, Chandran ; Edwards, John ; Findling, Robert L.
Publisher:Cham: Springer International Publishing
Journal title:Paediatric drugs, 2018-08, Vol.20 (4), p.353-363
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 18
ArticlesPeer ReviewedFull Text
A DOUBLE‐BLIND, RANDOMIZED, PLACEBO‐CONTROLLED, FIXED‐DOSE PHASE III STUDY OF VILAZODONE IN PATIENTS WITH GENERALIZED ANXIETY DISORDER
Author / Creator:Gommoll, Carl ; Durgam, Suresh ; Mathews, Maju ; Forero, Giovanna ; Nunez, Rene ; Tang, Xiongwen ; Thase, Michael E.
Publisher:United States: John Wiley & Sons, Inc
Journal title:Depression and anxiety, 2015-06, Vol.32 (6), p.451-459
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 19
ArticlesPeer ReviewedFull Text
186 Results From a 12-Month Open-label Safety Study of Lumateperone (ITI-007) in Patients with Stable Symptoms of Schizophrenia
Author / Creator:Correll, Christoph U. ; Vanover, Kimberly E ; Durgam, Suresh ; Davis, Robert ; Rowe, William ; Mates, Sharon ; Satlin, Andrew
Publisher:United States: Cambridge University Press
Journal title:CNS spectrums, 2020-04, Vol.25 (2), p.317-318
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 20
ArticlesPeer ReviewedFull Text
185 The Safety and Tolerability of Lumateperone 42 mg for the Treatment of Schizophrenia: A Pooled Analysis of 3 Randomized Placebo-Controlled Trials
Author / Creator:Kane, John M ; Vanover, Kimberly E ; Durgam, Suresh ; Davis, Robert ; Satlin, Andrew ; Rowe, William ; Mates, Sharon ; Tamminga, Carol
Publisher:United States: Cambridge University Press
Journal title:CNS spectrums, 2020-04, Vol.25 (2), p.316-317
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Showing 1 to 20 of 33 results

Export record to excel

Export this record

Export record to excel

Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial

Export this record

Export record to excel

The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis

Export this record

Export record to excel

Relationship Between Plasma Concentrations and Clinical Effects of Cariprazine in Patients With Schizophrenia or Bipolar Mania

Export this record

Export record to excel

Lumateperone in Pooled Late-Phase Schizophrenia Trials: Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed

Export this record

Export record to excel

LUMATEPERONE IN THE TREATMENT OF PATIENTS WITH MAJOR DEPRESSIVE DISORDER AND BIPOLAR DISORDER WITH ANXIOUS DISTRESS AND MIXED FEATURES

Export this record

Export record to excel

LUMATEPERONE TREATMENT FOR MAJOR DEPRESSIVE EPISODES WITH MIXED FEATURES IN MAJOR DEPRESSIVE DISORDER AND BIPOLAR I OR BIPOLAR II DISORDER

Export this record

Export record to excel

Safety and tolerability of cariprazine in the long-term treatment of schizophrenia: results from a 48-week, single-arm, open-label extension study

Export this record

Export record to excel

Lumateperone 42 mg in an Open-Label Switch Study in Patients with Stable Schizophrenia: Results by Previous Antipsychotic

Export this record

Export record to excel

Metabolic Syndrome in Bipolar Depression with Lumateperone (ITI-007): A Post Hoc Analysis of 2 Randomized, Placebo-Controlled Trials

Export this record

Export record to excel

Effect of Lumateperone (ITI-007) on Quality of Life and Functional Disability in the Treatment of Bipolar Depression

Export this record

Export record to excel

Long-Term Lumateperone Treatment in Bipolar Disorder: Six-Month Open-Label Extension Study

Export this record

Export record to excel

Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [11C]-(+)-PHNO

Export this record

Export record to excel

S221. THE EFFICACY OF LUMATEPERONE 42 MG IN THE TREATMENT OF SCHIZOPHRENIA SYMPTOMS ASSOCIATED WITH SOCIAL FUNCTIONING: POST HOC ANALYSIS OF AN ACUTE PLACEBO- AND ACTIVE-CONTROLLED TRIAL

Export this record

Export record to excel

M205. LONG-TERM SAFETY OF LUMATEPERONE (ITI-007): METABOLIC EFFECTS IN A 1-YEAR STUDY

Export this record

Export record to excel

T205. LUMATEPERONE IN THE TREATMENT OF SCHIZOPHRENIA: EVALUATION OF EXTRAPYRAMIDAL AND MOTOR SYMPTOMS IN 4 LATE-PHASE CLINICAL TRIALS

Export this record

Export record to excel

Evaluation of the long-term safety and tolerability of cariprazine in patients with schizophrenia: results from a 1-year open-label study

Export this record

Export record to excel

A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Vilazodone in Adolescents with Major Depressive Disorder

Export this record

Export record to excel

A DOUBLE‐BLIND, RANDOMIZED, PLACEBO‐CONTROLLED, FIXED‐DOSE PHASE III STUDY OF VILAZODONE IN PATIENTS WITH GENERALIZED ANXIETY DISORDER

Export this record

Export record to excel

186 Results From a 12-Month Open-label Safety Study of Lumateperone (ITI-007) in Patients with Stable Symptoms of Schizophrenia

Export this record

Export record to excel

185 The Safety and Tolerability of Lumateperone 42 mg for the Treatment of Schizophrenia: A Pooled Analysis of 3 Randomized Placebo-Controlled Trials

Refine your search